Literature DB >> 9194525

Different roles of D-amino acids in immune phenomena.

M Sela1, E Zisman.   

Abstract

Peptides and polypeptides either fully or partially built of D-amino acids interest researchers because of their advantages over all L peptides and polypeptides. In exploiting these characteristics, one should realize that the resulting molecules are nonetheless not inert, but rather may induce a unique immune response, which is hardly cross-reactive with the L-enantiomer. Moreover, cross-reaction between the L- and the D-sequences is limited also at the T cell level, probably due to different sterical conformations of the MHC-antigen-T cell receptor complexes formed. Polypeptides built exclusively of D-amino acids lead to antibody formation only at a relatively low concentration, otherwise they provoke immunological paralysis. The specificity of the immune response toward peptides containing D-amino acid residues is exquisite, and often D-amino acids play a dominant role in defining the specificity. Polypeptides composed exclusively of D-amino acids are thymus-independent antigens. Nevertheless, it is possible to prepare against them highly specific T cell hybridomas. In future plans for synthetic vaccines against infectious or autoimmune diseases, the inclusion of D-amino acids may be an advantage in terms of both specificity and efficacy, the latter because of longer persistence in an undigested form because they resist enzymatic degradation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194525     DOI: 10.1096/fasebj.11.6.9194525

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1.

Authors:  J R Sydor; C Herrmann; S B Kent; R S Goody; M Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Probing into the realm of proteins and immunity.

Authors:  M Sela
Journal:  Protein Sci       Date:  1998-07       Impact factor: 6.725

3.  Computational design of an endo-1,4-beta-xylanase ligand binding site.

Authors:  Andrew Morin; Kristian W Kaufmann; Carie Fortenberry; Joel M Harp; Laura S Mizoue; Jens Meiler
Journal:  Protein Eng Des Sel       Date:  2011-02-24       Impact factor: 1.650

4.  Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.

Authors:  Miloslav Kverka; Jonathan M Hartley; Te-Wei Chu; Jiyuan Yang; Regina Heidchen; Jindřich Kopeček
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

Review 5.  D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics.

Authors:  Huaimin Wang; Zhaoqianqi Feng; Bing Xu
Journal:  Adv Drug Deliv Rev       Date:  2016-04-19       Impact factor: 15.470

6.  Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.

Authors:  Nina Bionda; Maciej Stawikowski; Roma Stawikowska; Maré Cudic; Fabian López-Vallejo; Daniela Treitl; José Medina-Franco; Predrag Cudic
Journal:  ChemMedChem       Date:  2012-03-05       Impact factor: 3.466

7.  Nature versus design: the conformational propensities of D-amino acids and the importance of side chain chirality.

Authors:  Clare-Louise Towse; Gene Hopping; Ivan Vulovic; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2014-09-18       Impact factor: 1.650

8.  Combinatorial Library Screening with Liposomes for Discovery of Membrane Active Peptides.

Authors:  Randy P Carney; Yann Thillier; Zsofia Kiss; Amir Sahabi; Jean Carlos Heleno Campos; Alisha Knudson; Ruiwu Liu; David Olivos; Mary Saunders; Lin Tian; Kit S Lam
Journal:  ACS Comb Sci       Date:  2017-04-13       Impact factor: 3.784

9.  Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide.

Authors:  Regina Tugyi; Katalin Uray; Dóra Iván; Erzsébet Fellinger; Alan Perkins; Ferenc Hudecz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

10.  Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers.

Authors:  Leonie H E Leithold; Nan Jiang; Julia Post; Tamar Ziehm; Elena Schartmann; Janine Kutzsche; N Jon Shah; Jörg Breitkreutz; Karl-Josef Langen; Antje Willuweit; Dieter Willbold
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.